Baxdrostat

• A Phase IIb study to evaluate the effect of combination of dapagliflozin and baxdrostat compared with baxdrostat alone in participants with … Recruiting
  2025-522407-23-00 Phase II 2 countries AstraZeneca AB
• A trial to learn how safe baxdrostat is and how well it works in adults with primary aldosteronism Recruiting
  2025-520740-16-00 Phase III 4 countries AstraZeneca AB
• A trial to learn how well baxdrostat with dapagliflozin works compared to dapagliflozin on clinical outcomes alone and how safe it is in adu… Recruiting
  2023-506460-14-00 Phase III 15 countries Astrazeneca AB
• A trial to learn how well baxdrostat with dapagliflozin works compared to dapagliflozin alone and how safe it is in adults with chronic kidn… Ended
  2023-506457-38-00 Phase III 15 countries Astrazeneca AB
• A clinical research study to learn if baxdrostat works at reducing ambulatory blood pressure and is safe for people with high blood pressure… Ended
  2023-507640-36-00 Phase III 9 countries Astrazeneca AB
• A study to learn if baxdrostat works at reducing blood pressure and is safe in people with high blood pressure Ended
  2023-505499-32-00 Phase III 14 countries Astrazeneca AB

Showing 1–6 of 6 trials